US scientists have developed a new potentially inhalable vaccine against Ebola that could help lead to effective treatment. The aerosol vaccine is the subject of a study headed by researchers at the University of Texas Medical Branch (UTMB) in Galveston and the National Institutes of Health (NIH). A series of tests run on rhesus monkeys proved the vaccine to be effective despite previous failed attempt at vaccines.
However, the aerosol vaccine’s success on rhesus monkeys is not necessarily indicative of its effectiveness in humans, as previously developed medications failed to prevent the disease. More>>
Tulane University School of Public Health and Tropical Medicine currently conducts interdisciplinary research on Ebola and other infectious diseases. Learn more about Tulane’s role in the Ebola outbreak.